The IPL 2026 continues to grow as cricket's biggest commercial spectacle, attracting global stars, billion-dollar investments, and unprecedented performance pressure. But while the on-field quality of the tournament remains elite, fresh data from India's National Anti-Doping Agency (NADA) has raised uncomfortable questions about the league's anti-doping vigilance.
According to publicly available NADA records, the volume of anti-doping tests conducted during IPL 2026 has dropped sharply compared to previous seasons, particularly during April - the most intense phase of the tournament calendar.
The decline may not automatically imply wrongdoing, but in an era where sports integrity is under constant scrutiny globally, reduced testing inevitably
creates perception concerns.
IPL 2026 Witnessed a Significant Reduction in Dope Tests
The most striking statistic is the decline in April testing numbers.
| Period | 2025 Tests | 2026 Tests | Difference | % Change |
|---|---|---|---|---|
| April | 48 | 27 | -21 | -43.75% |
| Comparable Total | 60 (Apr+May) | 42 (Feb+Mar+Apr) | -18 | -30% |
April 2026 saw only 27 anti-doping tests compared to 48 during the same month in IPL 2025 - a reduction of nearly 44 percent.
Considering April is traditionally the busiest phase of the IPL season with packed schedules, travel fatigue, and maximum player participation, the reduced testing volume stands out sharply.
Monthly Testing Breakdown in IPL 2026
| Month | Tests Conducted | Phase |
|---|---|---|
| February 2026 | 5 | Pre-season |
| March 2026 | 10 | Early season |
| April 2026 | 27 | Peak league phase |
| Total | 42 | Up to April |
May 2026 data is still awaited. For context, NADA conducted 12 tests in May 2025 and 17 in May 2024.
If May numbers fail to rebound significantly, IPL 2026 could end up recording one of the lowest anti-doping testing volumes in recent seasons.
Indian Player Testing Fell Dramatically
The decline becomes even more noticeable when player categories are examined closely.
| Metric | April 2025 | April 2026 | Change |
|---|---|---|---|
| Total Tests | 48 | 27 | -43.75% |
| Unique Players | 48 | 27 | -43.75% |
| Indian Players | 43 | 21 | -51.16% |
| Overseas Players | 5 | 6 | +20% |
| Batters | 24 | 14 | -41.67% |
| Bowlers | 18 | 9 | -50% |
| All-rounders / Wicketkeepers | 6 | 4 | -33.33% |
One notable trend is that Indian player testing dropped by more than 50 percent, while overseas player testing slightly increased proportionally.
The testing pool in 2026 also appears more selective and concentrated around high-profile names.
Which IPL Players Were Tested in 2026?
Among the players tested during April 2026 were:
- Jasprit Bumrah
- Rohit Sharma
- Ishan Kishan
- Shubman Gill
- Ruturaj Gaikwad
- Josh Hazlewood
- Kagiso Rabada
- Glenn Phillips
Meanwhile, repeat testing remained extremely limited. Abdul Samad and Arshdeep Singh were among the few players tested more than once during the early phase of 2026.
Why Has NADA Reduced IPL Testing?
There are several possible explanations behind the decline.
1. Resource Allocation: NADA may be balancing resources across multiple international and domestic sporting events simultaneously. India's expanding sporting calendar places enormous operational pressure on anti-doping infrastructure.
2. Shift Towards Targeted Testing: Modern anti-doping systems increasingly rely on intelligence-based testing rather than blanket random checks. NADA may be prioritising a smaller Registered Testing Pool (RTP) featuring high-risk or high-profile athletes.
3. Logistical Complexity: The IPL's multi-city schedule creates unique logistical challenges. Teams constantly travel, player availability changes rapidly, and coordinating surprise testing becomes expensive and operationally demanding.
4. Strategic Policy Changes: There may also be an internal strategic shift toward fewer but more targeted tests instead of broader volume-based screening.
Why Perception Matters for IPL's Integrity
The IPL has historically witnessed very few doping controversies compared to several other global sporting leagues. But in elite sport, anti-doping systems are judged not only by violations caught, but by the confidence they create.
A 44 percent drop during the busiest month of the tournament naturally raises questions about monitoring standards.
This becomes especially relevant in a season where multiple players have delivered extraordinary performances, massive workload volumes, and record-breaking intensity levels.
The concern here is not necessarily evidence of wrongdoing - it is whether the system appears rigorous enough to eliminate doubt entirely.
Much will depend on the release of May 2026 testing data.
